Status:
COMPLETED
Molecular Characterization of Primary Mucosal Melanoma
Lead Sponsor:
CHU de Reims
Conditions:
Mucosal Melanoma
Eligibility:
All Genders
18+ years
Brief Summary
Primary mucosal melanomas (MPM) are rarer than cutaneous melanomas, but also more severe. They are usually refractory to conventional approaches, regularly excluded from major therapeutic programs and...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Incident Mucosal melanoma in the Champagne-Ardenne region 2004-2014
- Exclusion criteria:
- Cutaneous melanoma
- Uveal melanoma
Exclusion
Key Trial Info
Start Date :
August 28 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 28 2021
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT03319693
Start Date
August 28 2017
End Date
April 28 2021
Last Update
August 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Reims
Reims, France, 51092